Genetic risk and its role in primary prevention of CAD

Abstract

Coronary artery disease (CAD) is a pandemic disease and the number one cause of death in the world. Predisposition to CAD is about 50% acquired and 50% genetic. CAD prevention has been proven in randomized clinical trials with statin therapy. However, primary prevention is limited by the lack of biomarkers to detect asymptomatic young individuals at risk. Traditional risk factors (TRFs) such as hypertension or Type 2 Diabetes are age-dependent and often not present until the sixth or seventh decade. In contrast, genetic risk determined at conception is potentially a biomarker to detect young individuals at risk for CAD. The first genetic risk variant for CAD (9p21) was discovered in 2007, and subsequently, over 200 risk variants for CAD were discovered. A genetic risk score (GRS) based on the genetic risk variants for CAD was evaluated in over one million individuals. Retrospective analysis of clinical trials assessing the effect of statin therapy showed that individuals with the highest GRS had the highest risk for cardiac events and also the most benefit from lowering cholesterol. In a recent study of 55,685 individuals, those with the highest GRS (20%) had a 91% higher risk for cardiac events. Furthermore, those with high genetic risk on a favorable lifestyle had 46% fewer cardiac events than those with an unfavorable lifestyle. The GRS is superior and independent of TRFs. Incorporation into clinical practice will be a paradigm shift in preventing this pandemic.

Keywords

Genetics / genetic risk variants for CAD / GWAS / primary prevention / CAD

References

[1] MurrayCJ.Measuring the global burden of disease.N Engl J Med2013;369:448-57

[2] Lloyd-jonesDM,BeiserA.Lifetime risk of developing coronary heart disease.Lancet1999;353:89-92

[3] ChanL.Gene-environment interactions and gene therapy in atherosclerosis.Cardiol Rev1994;2:130-7

[4] EnosWF,BeyerJ.Coronary disease among United States soldiers killed in action in Korea; preliminary report.J Am Med Assoc1953;152:1090-3

[5] FerenceBA,GrahamI.Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel.Eur Heart J2017;38:2459-72 PMCID:PMC5837225

[6] Navar-BogganAM,D’AgostinoRB Sr,SnidermanAD.Hyperlipidemia in early adulthood increases long-term risk of coronary heart disease.Circulation2015;131:451-8

[7] LibbyP.Interleukin-1 beta as a target for atherosclerosis therapy: biological basis of cantos and beyond.J Am Coll Cardiol2017;70:2278-89 PMCID:PMC5687846

[8] CholesterolTreatment Trialists,BlackwellL.Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials.Lancet2010;376:1670-81 PMCID:PMC2988224

[9] CollinsR,EmbersonJ.Interpretation of the evidence for the efficacy and safety of statin therapy.Lancet2016;388:2532-61

[10] Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S).Lancet1994;344:1383-89

[11] RobertsR.PCSK9 inhibition-a new thrust in the prevention of heart disease: genetics does it again.Can J Cardiol2013;29:899-901

[12] AbifadelM,RabèsJP.Mutations in PCSK9 cause autosomal dominant hypercholesterolemia.Nat Genet2003;34:154-6

[13] CohenJ,KotowskiIK,GarciaCK.Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9.Nat Genet2005;37:161-5

[14] SteinEA,YancopoulosGD.Effect of a monoclonal antibody to PCSK9 on LDL cholesterol.N Engl J Med2012;366:1108-18

[15] KösterA,MosiorM.Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism.Endocrinology2005;146:4943-50

[16] ShimamuraM,YasumoH.Angiopoietin-like protein3 regulates plasma HDL cholesterol through suppression of endothelial lipase.Arterioscler Thromb Vasc Biol2007;27:366-72

[17] RaalFJ,ReeskampLF.Evinacumab for homozygous familial hypercholesterolemia.N Engl J Med2020;383:711-20

[18] FujimotoK,ShimizugawaT.Angptl3-null mice show low plasma lipid concentrations by enhanced lipoprotein lipase activity.Exp Anim2006;55:27-34

[19] DeweyFE,DunbarRL.Genetic and pharmacologic inactivation of ANGPTL3 and cardiovascular disease.N Engl J Med2017;377:211-21 PMCID:PMC5800308

[20] AllenG,ShieldsJ.Measures of twin concordance.Acta Genet Stat Med1967;17:475-81

[21] HopkinsPN,KuidaH.Family history as an independent risk factor for incident coronary artery disease in a high-risk cohort in Utah.Am J Cardiol1988;62:703-7

[22] Lloyd-JonesDM,D’AgostinoRB Sr.Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults: a prospective study of parents and offspring.JAMA2004;291:2204-11

[23] YusufS,ÔunpuuS.Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study.Lancet2004;364:937-52

[24] CooperJA,HumphriesSE.A comparison of the PROCAM and Framingham point-scoring systems for estimation of individual risk of coronary heart disease in the Second Northwick Park Heart Study.Atherosclerosis2005;181,93-100

[25] RischN.The future of genetic studies of complex human diseases.Science1996;273:1516-7

[26] LanderES.The new genomics: global views of biology.Science1996;274:536-9

[27] ReichDE.On the allelic spectrum of human disease.Trends Genet2001;17:502-10

[28] LohmuellerKE,PikeM,HirschhornJN.Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease.Nat Genet2003;33:177-82

[29] WangDG,SiaoCJ.Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome.Science1998;280:1077-82

[30] MarianAJ,RobertsR. Mendelian basis of congenital and other cardiovascular diseases. In: Fuster V, Harrington RA, Narula J, Eapen ZJ, editors. Hurst’s The Heart. 14th ed. McGraw-Hill Education; 2017. Available from: https://accessmedicine.mhmedical.com/content.aspx?aid=1161732392 [Last accessed on 18 Aug 2022].

[31] KruglyakL.Prospects for whole-genome linkage disequilibrium mapping of common disease genes.Nat Genet1999;22:139-44

[32] MorganTM,LiftonRP.Nonvalidation of reported genetic risk factors for acute coronary syndrome in a large-scale replication study.JAMA2007;297:1551-61

[33] AnandSS,PareG.Genetic variants associated with myocardial infarction risk factors in over 8000 individuals from five ethnic groups: interheart study.Circ Cardiovas Genet2009;2:16-25

[34] Human Genome Sequencing Consortium. Finishing the euchromatic sequence of the human genome.Nature2004;431:931-45

[35] InternationalHapMap Consortium,BallingerDG.A second generation human haplotype map of over 3.1 million SNPs.Nature2007;449:851-61 PMCID:PMC2689609

[36] StrangerBE,DunningM.Relative impact of nucleotide and copy number variation on gene expression phenotypes.Science2007;315:848-53 PMCID:PMC2665772

[37] RobertsR.New gains in understanding coronary artery disease, interview WITH Dr Robert Roberts.Affymetrix Microarray Bulletin2007;3:1-4

[38] ThomasDC,DugganD.Recent developments in genomewide association scans: a workshop summary and review.Am J Hum Genet2005;77:337-45 PMCID:PMC1226200

[39] ChanockSJ,BoehnkeM.Replicating genotype-phenotype associations.Nature2007;447:655-60

[40] McPhersonR,KavaslarN.A common allele on chromosome 9 associated with coronary heart disease.Science2007;316:1488-91 PMCID:PMC2711874

[41] HelgadottirA,ManolescuA,BlondalT.A common variant on chromosome 9p21 affects the risk of myocardial infarction.Science2007;316:1491-3

[42] Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls.Nature2007;447:661-78

[43] O’DonnellCJ,SmithAV.Genome-wide association study for coronary artery calcification with follow-up in myocardial infarction.Circulation2011;124:2855-64 PMCID:PMC3397173

[44] WangF,HeQ.Genome-wide association identifies a susceptibility locus for coronary artery disease in the Chinese Han population.Nat Genet2011;43:345-9

[45] ShenGQ,RaoS.Four SNPs on chromosome 9p21 in a South Korean population implicate a genetic locus that confers high cross-race risk for development of coronary artery disease.Arterioscler Thromb Vasc Biol2008;28:360-5

[46] ShenGQ,MartinelliN.Association between four SNPs on chromosome 9p21 and myocardial infarction is replicated in an Italian population.J Hum Genet2007;53:144-50

[47] HinoharaK,TakahashiM.Replication of the association between a chromosome 9p21 polymorphism and coronary artery disease in Japanese and Korean populations.J Hum Genet2008;53:357-9

[48] Coronary Artery Disease (C4D) Genetics Consortium. A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease.Nat Genet2011;43:339-44

[49] IribarrenC,JorgensonE.Weighted multi-marker genetic risk scores for incident coronary heart disease among individuals of african, latino and east-asian ancestry.Sci Rep2018;8:6853 PMCID:PMC5931622

[50] AssimesTL,BasuA.Susceptibility locus for clinical and subclinical coronary artery disease at chromosome 9p21 in the multi-ethnic ADVANCE study.Hum Mol Genet2008;17:2320-8 PMCID:PMC2733811

[51] PreussM,ThompsonJR.Design of the coronary artery disease genome-wide replication and meta-analysis (CARDIoGRAM) study: a genome-wide association meta-analysis involving more than 22,000 cases and 60,000 controls.Circ Cardiovasc Genet2010;3:475-83 PMCID:PMC3070269

[52] SchunkertH,KathiresanS.Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease.Nat Genet2011;43:333-8 PMCID:PMC3119261

[53] DeloukasP,WillenborgC.Large-scale association analysis identifies new risk loci for coronary artery disease.Nat Genet2013;45:25-33 PMCID:PMC3679547

[54] NikpayM,WonHH.A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease.Nat Genet2015;47:1121-30 PMCID:PMC4589895

[55] der Harst P, Verweij N. Identification of 64 novel genetic loci provides an expanded view on the genetic architecture of coronary artery disease.Circ Res2018;122:433-43 PMCID:PMC5805277

[56] NelsonC,ButterworthA.Association analyses based on false discovery rate implicate new loci for coronary artery disease.Nat Genet2017;49:1385-91

[57] RobertsR.Genetics of coronary artery disease.Circ Res2014;114:1890-903

[58] KheraAV.Genetics of coronary artery disease: discovery, biology and clinical translation.Nat Rev Genet2017;18:331-44 PMCID:PMC5935119

[59] AssimesTL.Genetics: implications for prevention and management of coronary artery disease.J Am Coll Cardiol2016;68:2797-818

[60] RobertsR.A journey through genetic architecture and predisposition of coronary artery disease.Curr Genomics2020;21:382-98 PMCID:PMC7536803

[61] ErdmannJ,MunozVenegas L.A decade of genome-wide association studies for coronary artery disease: the challenges ahead.Cardiovasc Res2018;114:1241-57

[62] NelsonCP,SaleheenD.Genetically determined height and coronary artery disease.N Engl J Med2015;372:1608-18 PMCID:PMC4648271

[63] TadaH,LouieJZ.Risk prediction by genetic risk scores for coronary heart disease is independent of self-reported family history.Eur Heart J2016;37:561-67 PMCID:PMC4744619

[64] SchunkertH,KesslerT,ZengL.Genetics of coronary artery disease in the light of genome-wide association studies.Clin Res Cardiol2018;107:2-9

[65] AbrahamG,BhalalaOG.Genomic prediction of coronary heart disease.Eur Heart J2016;37:3267-78 PMCID:PMC5146693

[66] SchunkertH.Family or SNPs: what counts for hereditary risk of coronary artery disease?.Eur Heart J2016;37:568-71

[67] RobertsR,HadleyT.Genetic risk stratification: a paradigm shift in prevention of coronary artery disease.JACC Basic Transl Sci2021;6:287-304 PMCID:PMC7987546

[68] DaviesRW,StewartAF.Improved prediction of cardiovascular disease based on a panel of single nucleotide polymorphisms identified through genome-wide association studies.Circ Cardiovasc Genet2010;3:468-74 PMCID:PMC3035486

[69] MegaJL,SmithJG.Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials.Lancet2015;385:2264-71 PMCID:PMC4608367

[70] NatarajanP,StitzielNO.Polygenic risk score identifies subgroup with higher burden of atherosclerosis and greater relative benefit from statin therapy in the primary prevention setting.Circulation2017;135:2091-101 PMCID:PMC5484076

[71] MarstonNA,NordioF.Predicting benefit from evolocumab therapy in patients with atherosclerotic disease using a genetic risk score: results from the Fourier trial.Circulation2020;141:616-23 PMCID:PMC8058781

[72] DamaskA,SchwartzGG.Patients with high genome-wide polygenic risk scores for coronary artery disease may receive greater clinical benefit from alirocumab treatment in the odyssey outcomes trial.Circulation2020;141:624-36

[73] InouyeM,NelsonCP.Genomic risk prediction of coronary artery disease in 480,000 adults.J Am Coll Cardiol2018;72:1883-93 PMCID:PMC6176870

[74] KheraAV,AragamKG.Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations.Nat Genet2018;50:1219-24 PMCID:PMC6128408

[75] CohenDE.Balancing cholesterol synthesis and absorption in the gastrointestinal tract.J Clin Lipidol2008;2:S1-3 PMCID:PMC2390860

[76] TabasI.Consequences of cellular cholesterol accumulation: basic concepts and physiological implications.J Clin Invest2002;110:905-11 PMCID:PMC151158

[77] TeslovichTM,SmithAV.Biological, clinical and population relevance of 95 loci for blood lipids.Nature2010;466:707-13 PMCID:PMC3039276

[78] KheraAV,DrakeI.Genetic risk, adherence to a healthy lifestyle, and coronary disease.N Engl J Med2016;375:2349-58 PMCID:PMC5338864

[79] TikkanenE,IngelssonE.Associations of fitness, physical activity, strength, and genetic risk with cardiovascular disease: longitudinal analyses in the UK Biobank study.Circulation2018;137:2583-91 PMCID:PMC5997501

[80] RobertsR.A Less than provocative approach for the primary prevention of CAD.J Cardiovasc Transl Res2022;15:95-102

[81] SwigerKJ,BlahaMJ.Narrowing sex differences in lipoprotein cholesterol subclasses following mid-life: the very large database of lipids (VLDL-10B).J Am Heart Assoc2014;3:e000851 PMCID:PMC4187479

[82] GrundySM,BaileyAL.2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the american college of cardiology/american heart association task force on clinical practice guidelines.Circulation2019;139:e1082-143

[83] RobertsR.Genetic risk stratification: tipping point for global primary prevention of coronary artery disease.Circulation2018;137:2554-6

[84] MarigortaUM.High trans-ethnic replicability of GWAS results implies common causal variants.PLoS Genet2013;9:e1003566 PMCID:PMC3681663

[85] WangM,MishraS.Validation of a genome-wide polygenic score for coronary artery disease in South Asians.J Am Coll Cardiol2020;76:703-14 PMCID:PMC7592606

[86] Riveros-MckayF,MooreR.Integrated polygenic tool substantially enhances coronary artery disease prediction.Circ Genom Precis Med2021;14:e003304 PMCID:PMC8284388